NEUROLOGISK KLINIK ApS: Financial statements 2014
CVR: 31748429
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 308,000 and a net result of DKK 191,641 compared with DKK 251,471 the year before. That is a decrease of 5.4% compared with the year before. The profit margin was 62.2%. Equity in the 2014 report amounted to DKK 419,352. The solvency ratio was 70.2%.
- Revenue
- DKK 308,000
- Gross Profit
- DKK 262,069
- Profit/Loss
- DKK 191,641
- Equity
- DKK 419,352
- Total Assets
- DKK 596,959
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 308K | 262K | 192K | 419K | - |
| 2013 | 326K | - | 251K | 228K | - |
| 2012 | 414K | 394K | 394K | -24K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of August 5, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NEUROLOGISK KLINIK ApS.
As of August 5, 2014, REVISOR KROGH ApS has stepped down as auditor of NEUROLOGISK KLINIK ApS.
NEUROLOGISK KLINIK ApS has published its annual report for 2013. Revenue came to DKK 325,500, and the net result was DKK 251,471.
About NEUROLOGISK KLINIK ApS
NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.